Search

The effective spread of COVID-19 cases in several countries produces more protein sequences that are released in genomic public sources. It provides some awareness and indications for virus classification of COVID-19 and HIV-1 that are essential for drug discovery of COVID-19. This paper reveals the importance of machine learning algorithms to handle the recognition of two different viruses. Therefore, 18,476 protein sequences for both COVID-19 and HIV-1 and 9238 for each virus are applied to the proposed model based on feature extraction, data labeling, and six classifiers. Amino acid classification according to their dipoles and volumes is employed as a feature extraction tool based on the creation of eight features from twenty amino acids by using the conjoint triad (CT) method. The data labeling is employed as a coding tool by binary numbers refereeing zero for COVID-19 and one for HIV-1. The random forest (RF) model achieved the highest classification accuracy of 99.89% for eight features and 97.80% for two features. The experimental results significantly confirmed that eight features required more computational time than two features, but the accuracy rate was nearly similar in the two cases. This classification strategy of COVID-19 and HIV-1 will prompt the prediction of protein sequences of the new virus. [ABSTRACT FROM AUTHOR]

The rapid spread of coronavirus disease (COVID-19) has become a worldwide pandemic and affected more than 15 million patients reported in 27 countries. Therefore, the computational biology carrying this virus that correlates with the human population urgently needs to be understood. In this paper, the classification of the human protein sequences of COVID-19, according to the country, is presented based on machine learning algorithms. The proposed model is based on distinguishing 9238 sequences using three stages, including data preprocessing, data labeling, and classification. In the first stage, data preprocessing's function converts the amino acids of COVID-19 protein sequences into eight groups of numbers based on the amino acids' volume and dipole. It is based on the conjoint triad (CT) method. In the second stage, there are two methods for labeling data from 27 countries from 0 to 26. The first method is based on selecting one number for each country according to the code numbers of countries, while the second method is based on binary elements for each country. According to their countries, machine learning algorithms are used to discover different COVID-19 protein sequences in the last stage. The obtained results demonstrate 100% accuracy, 100% sensitivity, and 90% specificity via the country-based binary labeling method with a linear support vector machine (SVM) classifier. Furthermore, with significant infection data, the USA is more prone to correct classification compared to other countries with fewer data. The unbalanced data for COVID-19 protein sequences is considered a major issue, especially as the US's available data represents 76% of a total of 9238 sequences. The proposed model will act as a prediction tool for the COVID-19 protein sequences in different countries. [ABSTRACT FROM AUTHOR]